171 related articles for article (PubMed ID: 37822234)
1. Comparison of International Ovarian Tumor Analysis ADNEX model and Ovarian-Adnexal Reporting and Data System with final histological diagnosis in adnexal masses: a retrospective study.
Filiz AA; Kahyaoglu S; Atalay CR
Obstet Gynecol Sci; 2024 Jan; 67(1):86-93. PubMed ID: 37822234
[TBL] [Abstract][Full Text] [Related]
2. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
Hiett AK; Sonek JD; Guy M; Reid TJ
Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
Poonyakanok V; Tanmahasamut P; Jaishuen A
J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
[TBL] [Abstract][Full Text] [Related]
5. O-RADS Classification for Ultrasound Assessment of Adnexal Masses: Agreement between IOTA Lexicon and ADNEX Model for Assigning Risk Group.
Vara J; Pagliuca M; Springer S; Gonzalez de Canales J; Brotons I; Yakcich J; Ajossa S; Pascual MA; Guerriero S; Alcazar JL
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832161
[TBL] [Abstract][Full Text] [Related]
6. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
7. Two-Step Strategy for Optimizing the Preoperative Classification of Adnexal Masses in a University Hospital, Using International Ovarian Tumor Analysis Models: Simple Rules and Assessment of Different NEoplasias in the adneXa Model.
Esquivel Villabona AL; Rodríguez JN; Ayala N; Buriticá C; Gómez AC; Velandia AM; Rodríguez N; Alcázar JL
J Ultrasound Med; 2022 Feb; 41(2):471-482. PubMed ID: 33890698
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
Wang R; Yang Z
Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
[TBL] [Abstract][Full Text] [Related]
10. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
Pozzati F; Sassu CM; Marini G; Mascilini F; Biscione A; Giannarelli D; Garganese G; Fragomeni SM; Scambia G; Testa AC; Moro F
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):594-602. PubMed ID: 37204769
[TBL] [Abstract][Full Text] [Related]
11. Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification.
Pelayo M; Sancho-Sauco J; Sánchez-Zurdo J; Perez-Mies B; Abarca-Martínez L; Cancelo-Hidalgo MJ; Sainz-Bueno JA; Alcázar JL; Pelayo-Delgado I
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685323
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses.
Pelayo M; Pelayo-Delgado I; Sancho-Sauco J; Sanchez-Zurdo J; Abarca-Martinez L; Corraliza-Galán V; Martin-Gromaz C; Pablos-Antona MJ; Zurita-Calvo J; Alcázar JL
Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046525
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
Chen GY; Hsu TF; Chan IS; Liu CH; Chao WT; Shih YC; Jiang LY; Chang YH; Wang PH; Chen YJ
Eur Radiol; 2022 Nov; 32(11):7854-7864. PubMed ID: 35583711
[TBL] [Abstract][Full Text] [Related]
14. Comparison of O-RADS, GI-RADS, and ADNEX for Diagnosis of Adnexal Masses: An External Validation Study Conducted by Junior Sonologists.
Lai HW; Lyu GR; Kang Z; Li LY; Zhang Y; Huang YJ
J Ultrasound Med; 2022 Jun; 41(6):1497-1507. PubMed ID: 34549454
[TBL] [Abstract][Full Text] [Related]
15. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women.
Nohuz E; De Simone L; Chêne G
J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):103-107. PubMed ID: 29709594
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
Yang Y; Ju H; Huang Y
Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Evaluation of the ADNEX Model for the Prediction of the Ovarian Cancer Risk of Adnexal Masses at Siriraj Hospital.
Poonyakanok V; Tanmahasamut P; Jaishuen A; Wongwananuruk T; Asumpinwong C; Panichyawat N; Chantrapanichkul P
Gynecol Obstet Invest; 2021; 86(1-2):132-138. PubMed ID: 33596584
[TBL] [Abstract][Full Text] [Related]
18. Simple rules, O-RADS, ADNEX and SRR model: Single oncologic center validation of diagnostic predictive models alone and combined (two-step strategy) to estimate the risk of malignancy in adnexal masses and ovarian tumors.
Spagnol G; Marchetti M; De Tommasi O; Vitagliano A; Cavallin F; Tozzi R; Saccardi C; Noventa M
Gynecol Oncol; 2023 Oct; 177():109-116. PubMed ID: 37660412
[TBL] [Abstract][Full Text] [Related]
19. Performance of IOTA Simple Rules Risks, ADNEX Model, Subjective Assessment Compared to CA125 and HE4 with ROMA Algorithm in Discriminating between Benign, Borderline and Stage I Malignant Adnexal Lesions.
Czekierdowski A; Stachowicz N; Smolen A; Łoziński T; Guzik P; Kluz T
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900029
[TBL] [Abstract][Full Text] [Related]
20. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
